Company: JUPGF
Filing Date: 2025-08-27
Form Type: DRS/A
Source: 0001493152-25-012379
Chunk: 140

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-08-27
Form: DRS/A
Chunk 140
---
, the holder of Series A Preferred shall not be entitled to a liquidation preference
over the holders of common stock, but shall share pro rata in any sum owed to the holders of our common in connection with a liquidation
event as if such Series A Preferred had been converted into common stock.

The Series A Preferred is convertible at
any time, upon ten days’ notice to us, into one share of our common stock at the option of the Series A Preferred holder.

For as long as there is one share of the Series
A Preferred outstanding, the holder of the Series A Preferred shall be entitled to nominate one director to our Board of
Directors.

As of the date of this prospectus, only one share
of our Series A Preferred has been issued and is outstanding, which share is held by Marc Fogassa, our Chairman and Chief Executive
Officer.

| 114 |

Undesignated Preferred Stock

As of the date of this prospectus, our Board of Directors
has the authority to issue up to 9,999,999 additional shares of preferred stock in one or more series and fix the number of shares constituting
any such series, the voting powers, designations, preferences and relative, participating, optional or other special rights and qualifications,
limitations or restrictions thereof, including the dividend rights, dividend rate, terms of redemption (including sinking fund provisions),
redemption price or prices, conversion rights and liquidation preferences of the shares constituting any series, without any further vote
or action by the stockholders. For example, the Board of Directors is authorized to issue preferred stock that would have the right to
vote, separately or with any other stockholder of preferred stock, on any proposed amendment to our certificate of incorporation, or on
any other proposed corporate action, including business combinations and other transactions.

We will not offer preferred stock unless the offering
is approved by a majority of our independent directors. The independent directors will have access, at our expense, to our counsel or
independent counsel.

Options and Warrants

As of the date of this prospectus, options and warrants to purchase up to 101,676 shares of our common stock (already reflecting the Reverse Stock Split) were issued and outstanding, with a weighted-average time of exercise of 3.48 years, and a weighted-average exercise price of $2.16.

As of the date of this prospectus, the Company does not have any outstanding warrants to purchase shares of our common stock.

Equity Awards

During the